Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-throughput acoustic FFPE proteomics reveals ATP5IF1-associated mitochondrial alterations in acral melanoma.

Molecular & cellular proteomics : MCP·2026
Same author

Ultrastructural alterations in the bronchial mucosa of patients with early interstitial lung disease associated with systemic sclerosis.

Clinical and experimental rheumatology·2026
Same author

From Primary Melanoma to Metastatic Evolution: AI-Powered Pathology Integrated with Functional Analysis and Clinical Metadata Improving Treatment Prediction.

Cancers·2026
Same author

Phosphoproteomic profiling reveals post-translational dysregulation in Huntington's disease patient-derived neurons.

Cellular & molecular biology letters·2026
Same author

Change in the chondroitin/dermatan structure in distal lung tissue from COPD patients.

Scientific reports·2026
Same author

Inhibition of Dermatan Sulfate Epimerase 1 by Substituted Glucuronic Acids.

ACS omega·2026

Related Experiment Video

Updated: Jun 12, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

Pathological airway remodelling in inflammation.

Gunilla Westergren-Thorsson1, Kristoffer Larsen, Kristian Nihlberg

  • 1Department of Experimental Medical Science, Lund University BMC D12, Lund, Sweden. gunilla.westergren-thorsson@med.lu.se

The Clinical Respiratory Journal
|May 27, 2010
PubMed
Summary

Airway remodelling involves dynamic fibroblast cells. Understanding their diverse origins and phenotypes is crucial for developing new diagnostic and therapeutic tools for conditions like asthma.

More Related Videos

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
04:45

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

Published on: June 2, 2022

Related Experiment Videos

Last Updated: Jun 12, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
04:45

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

Published on: June 2, 2022

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Pathophysiology

Background:

  • Airway remodelling involves smooth muscle cell hyperplasia, fibroblast activation, and extracellular matrix deposition.
  • In asthma, this includes epithelial changes, basement membrane thickening, and fibrosis, also seen in COPD and idiopathic pulmonary fibrosis.
  • Current asthma treatments like inhaled corticosteroids do not fully prevent airway remodelling.

Purpose of the Study:

  • To review the role of different fibroblast phenotypes in airway remodelling.
  • To explore the potential origins of these crucial cells.

Main Methods:

  • Literature review focusing on fibroblast differentiation and origins in airway remodelling.
  • Analysis of studies investigating myofibroblast phenotypes and sources.

Main Results:

  • Fibroblasts can differentiate into myofibroblasts during inflammation, expressing alpha-smooth muscle actin.
  • Identified origins of myofibroblasts include resident tissue fibroblasts, circulating fibrocytes, and epithelial-mesenchymal transition.
  • Airway mesenchymal cells exhibit greater dynamism in differentiation and origin than previously understood.

Conclusions:

  • Airway mesenchymal cells, including fibroblasts and myofibroblasts, are more dynamic than previously recognized.
  • Characterizing fibroblast phenotypes and differentiation drivers is essential for developing diagnostic and therapeutic tools.
  • Targeting these dynamic cells offers potential for future treatments in airway diseases like asthma.